DZ Bank
NTLA icon

DZ Bank’s Intellia Therapeutics NTLA Stock Holding History

DZ Bank’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-77,293
Closed -$2.36M – 1083
2023
Q4 		$2.36M Hold
77,293
– – ﹤0.01% 552
2023
Q3 		$2.44M Hold
77,293
– – ﹤0.01% 539
2023
Q2 		$3.15M Buy
+77,293
New +$3.13M ﹤0.01% 522
2022
Q2 		– Sell
-241,396
Closed -$17.5M – 1060
2022
Q1 		$17.5M Sell
241,396
-121,000
-33% -$10.3M 0.03% 277
2021
Q4 		$43.9M Hold
362,396
– – 0.06% 181
2021
Q3 		$48.6M Hold
362,396
– – 0.08% 161
2021
Q2 		$58.7M Hold
362,396
– – 0.1% 142
2021
Q1 		$29.1M Buy
+362,396
New +$24.3M 0.05% 207

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DZ Bank's NTLA Position: Q1 2024 in Review

DZ Bank sold out of Intellia Therapeutics (NTLA) in Q1 2024, closing a stake of 77,293 shares — an estimated $2.36M sold.

DZ Bank first reported a position in NTLA in Q1 2021 and held it in 8 quarters. The position peaked at $58.7M in Q2 2021. 284 funds tracked by Wall St. Rank hold NTLA as of Q1 2024.

  • DZ Bank reported no remaining Intellia Therapeutics position as of Q1 2024 after selling out during the quarter.
  • DZ Bank sold 77,293 Intellia Therapeutics shares in Q1 2024, an estimated $2.36M.
  • DZ Bank first reported a position in Intellia Therapeutics in Q1 2021 and held it in 8 quarters.
  • DZ Bank's Intellia Therapeutics position peaked at $58.7M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2024.

Based on DZ Bank's 13F filing for Q1 2024, filed 15 May 2024.